ALDEYRA THERAPEUTICS, INC. (ALDX) Operating cash flow 2016–2025
ALDEYRA THERAPEUTICS, INC. (ALDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$33.3MFY2025 · since FY2016: -$15.1M → -$33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.3M | +22.8% |
| FY2024 | -$43.2M | -42.5% |
| FY2023 | -$30.3M | +46.5% |
| FY2022 | -$56.6M | -33.1% |
| FY2021 | -$42.6M | -13.5% |
| FY2020 | -$37.5M | +16.7% |
| FY2019 | -$45.0M | -50.7% |
| FY2018 | -$29.9M | -55.3% |
| FY2017 | -$19.2M | -26.9% |
| FY2016 | -$15.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice